In:
HNO, Springer Science and Business Media LLC, Vol. 70, No. 9 ( 2022-09), p. 685-690
Kurzfassung:
Intratympanic steroids are a therapeutic component in sudden hearing loss related to cochlear affection. Little has been published on patients’ acceptance and tolerance to date. Materials and methods A total of 84 patients were asked about health conditions and circumstances surrounding their intratympanic therapy. Results The patients comprised 38 women and 46 men, aged 57.2 years on average, who had mostly been referred by their ENT physician for second-line treatment. Reported were injection pain by 3.6%, discomfort by 22.6%, tolerability by 67.9%, and painlessness by 41.7% (more than one answer possible). Whereas 77.4% recommended intratympanic treatment, reasons for no recommendation were lack of efficacy and an unpleasant sensation. Conclusion The majority of patients rated intratympanic therapy as bearable and recommendable. Close patient guidance seems to be an important part of the treatment.
Materialart:
Online-Ressource
ISSN:
0017-6192
,
1433-0458
DOI:
10.1007/s00106-022-01202-9
Sprache:
Deutsch
Verlag:
Springer Science and Business Media LLC
Publikationsdatum:
2022
ZDB Id:
1459183-2
